Clinical Trial: A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668999) titled 'A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes' on June 16.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled Phase 1b study in adult participants with tinea pedis caused by dermatophytes. The study will evaluate the safety, local tolerability, and pharmacokinetic profile of two concentrations of ZYG24004 (1% and 3%) after topical administration once or twice (once weekly for two consecutive weeks), and will explore preliminary efficacy.

Study Start Date: July 03

Study Type: INTERVENTIONAL

Condition: Tinea Pedis

Intervention: DRUG: ZYG24004 1% topical film...